Annual Report and Form 20-F 2022 Hello. We are Haleon. We are a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity. Our leading brands, built on science, innovation and deep human understanding, are trusted by millions of consumers globally. Packs shown are representative portfolio examples. Packaging will vary by country for linguistic, legal and regulatory reasons. Strategic Report Corporate Governance Financial Statements Other Information Our key s ...

Financial Performance - 2022 revenue reached £10.9 billion, representing a 13.8% increase from £9.5 billion in 2021[25] - Organic revenue growth was 9.0%, compared to a decline of 3.5% in 2021[25] - Operating profit margin improved to 16.8%, up from 17.2% in 2021[25] - Haleon reported strong revenue growth of 13.8% and organic revenue growth of 9.0% for 2022, driven by volume and price growth[48] - Adjusted operating profit increased from £2.1 billion in 2020 to £2.5 billion in 2022, reflecting a strong business model[80] - The company maintained a healthy balance of organic growth in 2022 with a 4.3% price increase and a 4.7% volume/mix growth[147] Growth Strategy - The company aims for annual organic revenue growth of 4-6% and sustainable moderate margin expansion[35] - Haleon aims for medium-term guidance of 4-6% annual organic revenue growth, supported by a strong brand portfolio and disciplined execution of strategy[50] - Haleon has identified significant growth opportunities in emerging markets, particularly in China and India[56] - The company is focused on increasing household penetration of its products and expanding its portfolio across channels and geographies[54] - The company aims to continue driving market share gains through brand building and increased investment in A&P and R&D[93] Product Development - A total of 52 product launches were executed, including new products and line extensions[30] - In 2022, Haleon launched 52 new innovations with an Adjusted R&D expenditure of £303 million, progressing over 250 active projects across all categories[141] - Haleon launched natural product variants in 2022, including Theraflu Naturals and Emergen-C Botanicals, targeting younger consumers[144] E-commerce and Sales Channels - E-commerce accounted for 9% of total sales, indicating increased channel penetration[30] - E-commerce sales grew by 16% in 2022, accounting for 9% of total sales, with the US and China seeing growth rates of 7% and 40% respectively[144] - Haleon aims to increase e-commerce sales to the mid-teens percentage by 2025, focusing on improving content and optimizing media[144] Financial Management - The company plans to reduce net debt/Adjusted EBITDA to less than 3x by 2024[35] - Net debt to Adjusted EBITDA ratio was 3.6x as of December 31, 2022, with a target to reduce it to below 3x by 2024[88][90] - The company has repaid £1.5 billion of its term loan since demerger, supported by strong cash flow and disciplined capital allocation[89] Environmental Commitment - The company aims to achieve 100% reduction in net Scope 1 and 2 carbon emissions by 2030, having already achieved 100% renewable electricity across its sites[98][99] - 65% of Haleon's packaging is recycle-ready, with a goal to develop recycle-ready solutions for all product packaging by 2025[103][105] - Haleon aims to achieve net zero carbon emissions from source to sale by 2040, with a 41% reduction in net Scope 1 and 2 carbon emissions reported in 2022[160][162] - The company plans to reduce the use of virgin petroleum-based plastic by 10% by 2025 and by one-third by 2030, based on the 2020 baseline[162] Employee Engagement and Culture - Employee engagement survey indicated that 80% of employees feel Haleon is fulfilling its core index measures, with a focus on improving identified areas[106] - The overall employee engagement index score for 2022 was 80%, with areas for improvement identified in work processes and opportunities for growth[21] - Haleon aims to achieve gender parity in its leadership community globally by 2030, targeting a representation of 48-52%[184] - The Global Parental Leave Policy provides 26 weeks of fully paid leave for all new parents, regardless of gender or family structure[187] Community and Social Responsibility - Haleon empowered 22.4 million people through health inclusivity initiatives in 2022, with a goal to reach 50 million by 2025[155] - Haleon donated over £1.7 million to the British Red Cross Ukraine Crisis Appeal in 2022 and launched the 'Haleon Helps' volunteering program in February 2023[157] Governance and Risk Management - The company is committed to upholding the UN Guiding Principles on Business and Human Rights and conducts annual human rights risk assessments[166] - Haleon has established a Global DEI Council to oversee diversity, equity, and inclusion initiatives, meeting quarterly to set priorities[186] - The company emphasizes the importance of embedding risk management in daily business operations[208]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File Number: 001-41411 Haleon plc (Translation of registrant's name into English) England and Wales (Jurisdiction of Incorporation) Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY (Address of principal executive offices) Indicate by check mark whether the registran ...

HALEON 2022 Half year results September 2022 Disclaimer This presentation contains certain statements that are, or may be deemed to be, "forward-looking statements" (including for purposes of the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934). Forward-looking statements give Haleon's current expectations and projections about future events, including strategic initiatives and future financia ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-41411 Haleon plc (Translation of registrant's name into English) England and Wales (Jurisdiction of Incorporation) Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY (Address of principal executive offices) Indicate by check mark whether the registrant files or ...